Enterprise Therapeutics has been awarded a block of funding from the Cystic Fibrosis Foundation to take a new, first-in-class drug for the genetic disorder through phase 2 testing. The Brighton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback